GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
F

Fennec Pharmaceuticals FENC · USD

Health Care · US listing · 🇺🇸 United States

Compare

10.83

+10.40%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Latest on Fennec Pharmaceuticals

Our reporting

Next results

12 Nov 2026

Due on 12 Nov 2026. Analysts expect earnings of 0.10 a share on revenue of $18.9m.

Past results

Reported against what analysts expected

11 Aug 202614 May 202624 Mar 202613 Nov 202514 Aug 202510 Mar 2025
Earnings per share0.050.01-0.17-0.02-0.11-0.06
Forecast0.02-0.020.03-0.08-0.060.56
Revenue$17.9m$15.1m$13.8m$12.5m$9.7m$7.9m
Forecast$16.2m$13.9m$14.7m$14.7m$9.6m$7.8m

Key events

  1. 5 Sept 20143-to-1 reverse split
  2. 30 Aug 201118-to-1 reverse split
  3. 2 Aug 20055-to-1 reverse split
  4. 5 Jun 2001Listed

Fennec Pharmaceuticals in the news

Headlines from other publishers, linked to their own pages.

Sources and methodology

Data on this tab
Our reporting and our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.